Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results (Q41899882)
Jump to navigation
Jump to search
scientific article published on 22 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results |
scientific article published on 22 November 2010 |
Statements
1 reference
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results (English)
1 reference
1 reference
1 reference
Hagop M Kantarjian
1 reference
Jorge Cortes
1 reference
Giovanni Martinelli
1 reference
Michele Baccarani
1 reference
Norbert Gattermann
1 reference
Jerald P Radich
1 reference
Philipp D le Coutre
1 reference
Yaping Shou
1 reference
Francis J Giles
1 reference
Javier Pinilla-Ibarz
1 reference
Rick Blakesley
1 reference
Kapil N Bhalla
1 reference
Timothy P Hughes
1 reference
Dong-Wook Kim
1 reference
Neil J Gallagher
1 reference
22 November 2010
1 reference
Identifiers
1 reference